ARCHIVES

Herceptin Reduces Recurrence In Early HER2+ Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 9 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

Pitt Criticizes NCI Stance On Repayment For Fraud Trials

September 9, 1994

NCI exceeds employment ceilings, must cut personnel in FY 2004, NIH says. Further cuts expected in extramural grant support staff.

January 30, 2004

NCI-Approved Clinical Trials

February 24, 2006

2015: “A Challenge For Our Generation,” AACR Says

July 18, 2003

“Miracle-Gro for Cancer?” ODAC Members Vent At Amgen And J&J Over Claims, Advertising.

May 18, 2007

Deals & Collaborations: UAB To Evaluate Firm’s Prostate Cancer Treatment

June 1, 2001